Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
B1613 Pyridostigmine BromideSummary: Reversible cholinesterase inhibitor
-
B6138 Itopride hydrochlorideSummary: AChE inhibitor
-
C3382 Hydroxytacrine (maleate)Summary: anticholinesterase activity
-
C4140 Edrophonium (chloride)Summary: acetylcholinesterase (AChE) inhibitor
-
C4052 Asoxime (chloride)Summary: AChE reactivator
-
C4594 bis(7)-TacrineSummary: AChE inhibitor
-
B5473 GSK 264220ASummary: endothelial lipase and lipoprotein lipase inhibitor
-
B5624 STF 083010Target: Inositol-requiring enzyme 1 (IRE1)Summary: IRE1α endonuclease inhibitor
-
B5745 KML 29Summary: monoacylglycerol lipase (MAGL) inhibitor
-
B5759 JW 642Summary: monoacylglycerol lipase (MAGL) inhibitor